Effects of eprosartan in 28 patients with non-proliferative diabetic retinopathy
| Baseline | 2 months | p Value | |
|---|---|---|---|
| Paired Wilcoxon test, all p = NS. Data presented as median and interquartile range. | |||
| VEGF, vascular endothelial growth factor; Ang-2, angiopoietin-2; tie-2, soluble angiopoietin receptor tie-2. | |||
| VEGF (pg/ml) | 135 (60–165) | 125 (70–220) | 0.367 |
| Ang-2 (ng/ml) | 2.0 (1.4–5.1) | 2.0 (1.4–13.8) | 0.899 |
| tie-2 (ng/ml) | 3.5 (1.8–11.0) | 5.0 (2.5–14.3) | 0.584 |









